The renoprotective potential of endothelin receptor antagonists
- 25 February 1997
- journal article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Patents
- Vol. 7 (2), 139-149
- https://doi.org/10.1517/13543776.7.2.139
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Endothelin-converting Enzyme-2 Is a Membrane-bound, Phosphoramidon-sensitive Metalloprotease with Acidic pH OptimumPublished by Elsevier ,1995
- Effect of a specific endothelin A receptor antagonist on murine lupus nephritisKidney International, 1995
- ECE-1: A membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1Cell, 1994
- Urinary Endothelin: A Possible Biological Marker of Renal DamageAmerican Journal of Hypertension, 1993
- Renal actions of endothelin peptidesCurrent Opinion in Nephrology and Hypertension, 1993
- DAILY RENAL HYPOPERFUSION INDUCED BY CYCLOSPORINE IN PATIENTS WITH RENAL TRANSPLANTATIONTransplantation, 1992
- INCREASED URINARY EXCRETION OF ENDOTHELIN-1 AND ITS PRECURSOR, BIG-ENDOTHELIN-1, IN RATS CHRONICALLY TREATED WITH CYCLOSPORINETransplantation, 1991
- Immunoreactive Endothelin in Urine of Patients With and Without Diabetes MellitusJournal of Cardiovascular Pharmacology, 1991
- Endothelin, a peptide inhibitor of Na(+)-K(+)-ATPase in intact renaltubular epithelial cellsAmerican Journal of Physiology-Cell Physiology, 1989
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988